Troxerutin suppresses the stemness of osteosarcoma via the CD155/SRC/β-catenin signaling axis

Abstract Background Osteosarcoma is the most prevalent primary malignant bone tumor affecting pediatric and adolescent individuals. However, despite the passage of three decades, there has been no notable enhancement in the overall survival rate of patients with osteosarcoma. In recent years, CD155...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Junkai Chen, Hongbo Li, Qinglin Jin, Xiaoguang Li, Yiwen Zhang, Jingnan Shen, Gang Huang, Junqiang Yin, Changye Zou, Xinyu Li, Xin He, Xianbiao Xie, Tiao Lin
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMC 2025-04-01
Schriftenreihe:	Cellular & Molecular Biology Letters
Schlagworte:	CD155 Osteosarcoma β-catenin Stemness Troxerutin
Online-Zugang:	https://doi.org/10.1186/s11658-025-00724-8
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!